Excellent - I now have comprehensive, authoritative data. Here is the full treatment guide:
UTI Treatment
Treatment depends on where the infection is (bladder vs. kidney), how severe it is (uncomplicated vs. complicated), and who the patient is (age, sex, pregnancy, immune status).
1. Uncomplicated Cystitis (Bladder Infection)
This is the most common form - typically a young, healthy, non-pregnant woman with lower urinary symptoms (burning, frequency, urgency) and no fever.
First-Line Antibiotics (Oral)
| Antibiotic | Dose | Duration | Notes |
|---|
| Nitrofurantoin (macrocrystals) | 100 mg twice daily | 5 days | Best clinical/microbiologic cure at 28 days; avoid if GFR is reduced |
| Trimethoprim-sulfamethoxazole (TMP-SMX) | 160/800 mg twice daily | 3 days | Only use if local E. coli resistance is <20% |
| Fosfomycin | 3 g single dose | 1 day | Convenient single dose; reserve when other options fail |
| Pivmecillinam | varies | 3-7 days | Used in Europe; limited availability elsewhere |
Fluoroquinolones (e.g., ciprofloxacin) are NOT recommended as first-line for uncomplicated cystitis due to toxicity concerns and resistance promotion. Beta-lactams (amoxicillin, cephalexin) are about 10% less effective than first-line agents but are preferred in pregnancy.
Symptomatic Relief (Adjunct Only)
- Phenazopyridine (Pyridium) 100-200 mg up to 3x/day for up to 2 days - provides topical urinary analgesia and relieves burning. Use alongside antibiotics, not instead of them. Turns urine/secretions orange - will stain contact lenses.
2. Pyelonephritis (Kidney Infection)
Presents with fever, chills, flank pain, nausea/vomiting, plus urinary symptoms.
Decision: Oral vs. IV?
| Oral (mild-moderate, no vomiting) | IV/Parenteral (severe, vomiting, sepsis) |
|---|
| Can treat outpatient | Hospital admission needed |
| Ciprofloxacin 500 mg bid x 5-7 days | Gentamicin (aminoglycoside) IV - best outcomes in high-resistance areas |
| Levofloxacin 750 mg once daily x 5 days | Step down to oral at 24-48 hours if improving |
| TMP-SMX or cefixime x 14 days | Total duration: 7-14 days (5-7 days if fluoroquinolone used) |
Important: Nitrofurantoin and fosfomycin do NOT achieve adequate tissue/renal levels - they must NOT be used for pyelonephritis.
3. Complicated UTI
A UTI is "complicated" when it occurs with:
- Structural/functional urinary tract abnormalities
- Urinary catheter in place
- Men, pregnant women, elderly, immunocompromised patients
- Diabetes, renal failure, recent hospitalization
- Known resistant organisms
Treatment is individualized based on:
- Culture and sensitivity results
- Site and severity of infection
- Likelihood of resistant organisms
Severe complicated UTI options (IV):
- Meropenem 1 g every 8 hours
- Piperacillin-tazobactam 4.5 g every 8 hours
- Plazomicin 15 mg/kg once daily (for highly resistant organisms)
- Meropenem-vaborbactam (for carbapenem-resistant bacteria)
Total duration: typically 10-14 days (IV x 4-5 days, then oral guided by culture).
4. Asymptomatic Bacteriuria
Bacteria in urine without symptoms - treat ONLY in:
- Pregnant women (risk of pyelonephritis and preterm birth)
- Before urologic procedures with expected mucosal trauma
For all other groups (elderly, catheterized patients, diabetics) - do NOT treat asymptomatic bacteriuria. It leads to no better outcomes and drives antimicrobial resistance.
5. UTI in Special Populations
| Group | Key Points |
|---|
| Pregnant women | Nitrofurantoin and oral cephalosporins preferred (safe for fetus); avoid TMP-SMX in 1st trimester and near term |
| Men | Often indicates complication (prostatitis, structural problem); treat for 7-14 days |
| Elderly | Symptoms are often atypical (confusion, falls); avoid over-diagnosing and over-treating |
| Recurrent UTI (women) | Options: patient-initiated self-treatment, continuous low-dose prophylaxis, or postcoital prophylaxis |
6. Prevention of Recurrent UTIs
For women with frequent recurrences (≥2/6 months or ≥3/year):
- Continuous low-dose prophylaxis - nitrofurantoin 50 mg nightly (most evidence)
- Postcoital prophylaxis - single dose after intercourse (if sexually triggered)
- Patient-initiated self-treatment - start antibiotics at first symptoms with pre-supplied prescription
- Behavioral measures - adequate hydration, urinate after intercourse, avoid spermicides
- Cranberry products - some evidence for prevention in women (not treatment)
- Vaginal estrogen - for post-menopausal women with atrophic vaginitis
Antibiotic Resistance Warning
Resistance rates to TMP-SMX and fluoroquinolones exceed 20% in many regions of the US and globally. Always consult local antibiogram data when selecting empiric therapy, and de-escalate based on culture results once available.
Sources: Goldman-Cecil Medicine, Table 263-6 & 263-7; Rosen's Emergency Medicine, Table 85.2; Harrison's Principles of Internal Medicine 22E (2025)